EE9700240A - Sidovudiini, 1592U89 ja 3TC või FTC sünergistlikud kombinatsioonid - Google Patents

Sidovudiini, 1592U89 ja 3TC või FTC sünergistlikud kombinatsioonid

Info

Publication number
EE9700240A
EE9700240A EE9700240A EE9700240A EE9700240A EE 9700240 A EE9700240 A EE 9700240A EE 9700240 A EE9700240 A EE 9700240A EE 9700240 A EE9700240 A EE 9700240A EE 9700240 A EE9700240 A EE 9700240A
Authority
EE
Estonia
Prior art keywords
ftc
zidovudine
synergistic combinations
synergistic
combinations
Prior art date
Application number
EE9700240A
Other languages
English (en)
Other versions
EE04047B1 (et
Inventor
Walter Barry David
Heider St. Clair Martha
Original Assignee
The Wellcome Foundation Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26306774&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EE9700240(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9506489.5A external-priority patent/GB9506489D0/en
Priority claimed from GBGB9506490.3A external-priority patent/GB9506490D0/en
Application filed by The Wellcome Foundation Limited filed Critical The Wellcome Foundation Limited
Publication of EE9700240A publication Critical patent/EE9700240A/et
Publication of EE04047B1 publication Critical patent/EE04047B1/et

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Medicinal Preparation (AREA)
  • Cephalosporin Compounds (AREA)
EE9700240A 1995-03-30 1996-03-28 Sidovudiini, 1592U89 ja 3TC või FTC sünergistlikud kombinatsioonid EE04047B1 (et)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9506489.5A GB9506489D0 (en) 1995-03-30 1995-03-30 Antiviral combinations
GBGB9506490.3A GB9506490D0 (en) 1995-03-30 1995-03-30 Antiviral combinations
PCT/EP1996/001352 WO1996030025A1 (en) 1995-03-30 1996-03-28 Synergistic combinations of zidovudine, 1592u89 and 3tc or ftc

Publications (2)

Publication Number Publication Date
EE9700240A true EE9700240A (et) 1998-04-15
EE04047B1 EE04047B1 (et) 2003-06-16

Family

ID=26306774

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9700240A EE04047B1 (et) 1995-03-30 1996-03-28 Sidovudiini, 1592U89 ja 3TC või FTC sünergistlikud kombinatsioonid

Country Status (36)

Country Link
US (1) US6417191B1 (et)
EP (1) EP0817637B1 (et)
JP (1) JP2954357B2 (et)
KR (1) KR100542536B1 (et)
CN (1) CN1103593C (et)
AP (1) AP652A (et)
AT (1) ATE220551T1 (et)
AU (1) AU715213B2 (et)
BR (3) BRPI9607851B8 (et)
CA (1) CA2216634C (et)
CZ (1) CZ295940B6 (et)
DE (3) DE69622386T2 (et)
DK (1) DK0817637T3 (et)
EA (1) EA000626B3 (et)
EE (1) EE04047B1 (et)
ES (1) ES2179193T3 (et)
FR (1) FR05C0022I2 (et)
GE (1) GEP20022647B (et)
HK (1) HK1009401A1 (et)
HU (1) HU224010B1 (et)
IL (1) IL117727A (et)
LU (1) LU91171I2 (et)
MX (1) MX9707316A (et)
MY (1) MY115461A (et)
NL (1) NL300195I2 (et)
NO (2) NO313787B1 (et)
NZ (1) NZ306419A (et)
OA (1) OA10616A (et)
PL (1) PL187085B1 (et)
PT (1) PT817637E (et)
RO (1) RO117995B1 (et)
SI (1) SI0817637T1 (et)
SK (1) SK283825B6 (et)
TR (1) TR199701074T1 (et)
UA (1) UA60293C2 (et)
WO (1) WO1996030025A1 (et)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL330747A1 (en) 1996-06-25 1999-05-24 Glaxo Group Ltd Vx478, zidovudin, ftc and/or 3tc containing combinations for use in treating hiv infections
US6113920A (en) * 1996-10-31 2000-09-05 Glaxo Wellcome Inc. Pharmaceutical compositions
TW536403B (en) * 1997-03-24 2003-06-11 Glaxo Group Ltd An ethanol and ethylenediaminetetraacetic acid free pharmaceutical composition comprising lamivudine and exhibiting antimicrobial preservative efficacy
AR012702A1 (es) * 1997-05-17 2000-11-08 Glaxo Group Ltd Combinacion de (-)-(1s,4r)-4-[2-amino-6-(ciclopropilamino)-9h-purin-9-il]- 2-ciclopenteno-1-metanol y un inhibidor dee transcriptasa reversa no nucleosidouna formulacion farmaceutica que comprende la combinacion, su uso medico en terapia para tratar la infeccion de vih, y un empaque para el paciente
GB9709945D0 (en) * 1997-05-17 1997-07-09 Glaxo Group Ltd A novel salt
AU769660B2 (en) * 1997-05-17 2004-01-29 Glaxo Group Limited Carbocyclic nucleoside hemisulfate and its use in treating viral infections
GB9809213D0 (en) * 1998-04-29 1998-07-01 Glaxo Group Ltd Pharmaceutical compositions
US6875773B1 (en) 1998-05-29 2005-04-05 Ben M. Dunn Combination therapy for treatment of FIV infection
EP1146882A2 (en) * 1998-05-29 2001-10-24 The University Of Florida Combination of zidovudine (azt) with nucleoside analogs for treatment of feline immunodeficiency virus
GB9820417D0 (en) * 1998-09-18 1998-11-11 Glaxo Group Ltd Antiviral combinations
US6432966B2 (en) 1999-10-29 2002-08-13 Smithkline Beecham Corporation Antiviral combinations
US7074417B2 (en) * 2000-10-13 2006-07-11 Advancis Pharmaceutical Corporation Multiple-delayed release anti-viral product, use and formulation thereof
AP2220A (en) * 2001-05-11 2011-03-24 Cipla Medpro Pty Ltd Pharmaceutical composition.
TW200403061A (en) * 2002-06-04 2004-03-01 Glaxo Group Ltd Pharmaceutical compositions
WO2004064846A1 (en) 2003-01-14 2004-08-05 Gilead Sciences, Inc. Compositions and methods for combination antiviral therapy
CN100469769C (zh) 2003-03-24 2009-03-18 弗·哈夫曼-拉罗切有限公司 作为逆转录酶抑制剂的苄基-哒嗪酮
CN1898569A (zh) 2003-10-24 2007-01-17 伊缪因艾德有限公司 治疗方法
TWI471145B (zh) 2005-06-13 2015-02-01 Bristol Myers Squibb & Gilead Sciences Llc 單一式藥學劑量型
BRPI0617720A2 (pt) 2005-10-19 2011-08-02 Hoffmann La Roche compostos inibidores de nnrt de fenil-acetamida, usos dos referidos compostos e composição farmacêutica que os contém
RU2469032C2 (ru) 2006-12-13 2012-12-10 Ф.Хоффманн-Ля Рош Аг Производные 2-(пиперидин-4-ил)-4-фенокси- или фениламинопиримидина в качестве ненуклеозидных ингибиторов обратной транскриптазы
JP5467870B2 (ja) * 2007-02-09 2014-04-09 アルファファーム ピーティーワイ リミテッド 異なる物理的形態の２種以上の有効医薬成分を含有する投薬形態
HUE026456T2 (en) 2009-05-27 2016-05-30 Biotempus Ltd Procedure for curing diseases
US20120295898A1 (en) 2010-01-27 2012-11-22 Mark Richard Underwood Antiviral Therapy
MX2016002560A (es) 2013-08-29 2016-10-26 Teva Pharma Forma de dosificacion unitaria que comprende emtricitabina, tenofovir, darunavir y ritonavir y un comprimido monolitico que comprende darunavir y ritonavir.
TW201622731A (zh) 2014-04-08 2016-07-01 泰瓦藥品工業有限公司 包含恩曲他濱（Ｅｍｔｒｉｃｉｔａｂｉｎｅ）、替諾福韋（Ｔｅｎｏｆｏｖｉｒ）、地瑞那韋（Ｄａｒｕｎａｖｉｒ）及利托那韋（Ｒｉｔｏｎａｖｉｒ）之單位劑型以及包含地瑞那韋及利托那韋之單層錠劑
EP3180349A4 (en) 2014-08-12 2018-08-22 Monash University Lymph directing prodrugs
CN118063537A (zh) 2015-09-08 2024-05-24 莫纳什大学 定向淋巴的前药
EP4306524A2 (en) * 2017-08-29 2024-01-17 PureTech LYT, Inc. Lymphatic system-directing lipid prodrugs
US11883497B2 (en) 2017-08-29 2024-01-30 Puretech Lyt, Inc. Lymphatic system-directing lipid prodrugs
US11608345B1 (en) 2017-12-19 2023-03-21 Puretech Lyt, Inc. Lipid prodrugs of rapamycin and its analogs and uses thereof
US11304954B2 (en) 2017-12-19 2022-04-19 Puretech Lyt, Inc. Lipid prodrugs of mycophenolic acid and uses thereof
IL295362A (en) 2020-02-05 2022-10-01 Puretech Lyt Inc Lipid drug inhibitors of neurosteroids

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4724232A (en) * 1985-03-16 1988-02-09 Burroughs Wellcome Co. Treatment of human viral infections
US5047407A (en) 1989-02-08 1991-09-10 Iaf Biochem International, Inc. 2-substituted-5-substituted-1,3-oxathiolanes with antiviral properties
US5122517A (en) 1988-06-10 1992-06-16 Regents Of The University Of Minnesota Antiviral combination comprising nucleoside analogs
GB8815265D0 (en) * 1988-06-27 1988-08-03 Wellcome Found Therapeutic nucleosides
US5204466A (en) 1990-02-01 1993-04-20 Emory University Method and compositions for the synthesis of bch-189 and related compounds
GB9009861D0 (en) * 1990-05-02 1990-06-27 Glaxo Group Ltd Chemical compounds
GB9104740D0 (en) * 1991-03-06 1991-04-17 Wellcome Found Antiviral nucleoside combination
AU1787492A (en) 1991-05-16 1992-12-30 Glaxo Group Limited Antiviral combinations containing nucleoside analogs
AU4079593A (en) 1992-05-13 1993-12-13 Wellcome Foundation Limited, The Therapeutic combinations
US5723490A (en) 1992-09-08 1998-03-03 Vertex Pharmaceuticals Incorporated THF-containing sulfonamide inhibitors of aspartyl protease
GB9417249D0 (en) 1994-08-26 1994-10-19 Wellcome Found A novel salt
US5869461A (en) 1995-03-16 1999-02-09 Yale University Reducing toxicity of L-nucleosides with D-nucleosides
PL330747A1 (en) 1996-06-25 1999-05-24 Glaxo Group Ltd Vx478, zidovudin, ftc and/or 3tc containing combinations for use in treating hiv infections
PE87398A1 (es) 1996-06-25 1999-01-15 Glaxo Group Ltd Combinaciones antivirales
DE10226522A1 (de) * 2002-06-14 2003-12-24 Degussa Verwendung von Übergangsmetallkomplexen mit stickstoffhaltigen mehrzähnigen Liganden als Bleichkatalysator und Bleichmittelzusammensetzung

Also Published As

Publication number Publication date
FR05C0022I1 (et) 2005-06-10
EA000626B3 (ru) 2016-04-29
JP2954357B2 (ja) 1999-09-27
CZ309097A3 (cs) 1998-05-13
SK129597A3 (en) 1998-07-08
NO2005014I2 (no) 2008-02-11
KR19980703420A (ko) 1998-11-05
AP9701089A0 (en) 1997-10-31
SI0817637T1 (en) 2002-10-31
HK1009401A1 (en) 1999-09-10
BRPI9612992B1 (pt) 2020-08-04
BRPI9607851B8 (pt) 2019-11-05
EP0817637A1 (en) 1998-01-14
PL187085B1 (pl) 2004-05-31
DE122005000029I1 (de) 2005-10-06
SK283825B6 (sk) 2004-02-03
WO1996030025A1 (en) 1996-10-03
BR9607851B1 (pt) 2009-01-13
EP0817637B1 (en) 2002-07-17
JPH10511682A (ja) 1998-11-10
CZ295940B6 (cs) 2005-12-14
IL117727A0 (en) 1996-07-23
NO974510D0 (no) 1997-09-29
AU5497296A (en) 1996-10-16
CN1103593C (zh) 2003-03-26
HU224010B1 (hu) 2005-04-28
DE122005000029I2 (de) 2006-04-27
EA000626B1 (ru) 1999-12-29
LU91171I9 (et) 2018-12-28
LU91171I2 (fr) 2005-07-04
CA2216634A1 (en) 1996-10-03
CN1185110A (zh) 1998-06-17
PL322532A1 (en) 1998-02-02
HUP9801571A3 (en) 2001-04-28
NL300195I2 (nl) 2005-11-01
NZ306419A (en) 2000-01-28
PT817637E (pt) 2002-11-29
MX9707316A (es) 1997-11-29
AP652A (en) 1998-06-19
ATE220551T1 (de) 2002-08-15
RO117995B1 (ro) 2002-12-30
DE69622386D1 (de) 2002-08-22
HUP9801571A2 (hu) 1999-01-28
NL300195I1 (nl) 2005-08-01
TR199701074T1 (xx) 1998-02-21
BR9607851A (pt) 1998-07-21
NO2005014I1 (no) 2005-06-06
KR100542536B1 (ko) 2006-03-23
MY115461A (en) 2003-06-30
IL117727A (en) 1999-11-30
OA10616A (en) 2001-03-15
NO313787B1 (no) 2002-12-02
GEP20022647B (en) 2002-03-25
DK0817637T3 (da) 2002-11-11
DE69622386T2 (de) 2003-02-13
ES2179193T3 (es) 2003-01-16
EA199700203A1 (ru) 1998-02-26
CA2216634C (en) 2004-07-20
AU715213B2 (en) 2000-01-20
NO974510L (no) 1997-09-29
US6417191B1 (en) 2002-07-09
UA60293C2 (uk) 2003-10-15
EE04047B1 (et) 2003-06-16
FR05C0022I2 (et) 2005-10-21

Similar Documents

Publication Publication Date Title
EE9700240A (et) Sidovudiini, 1592U89 ja 3TC või FTC sünergistlikud kombinatsioonid
EE03427B1 (et) Pihusti sõlm ja selle kasutamine
DK0871656T3 (da) Dolastatinderivater, deres fremstilling og anvendelse
DE69415157D1 (de) Elektrochirurgischer prozessor und anwendung
NL300295I2 (nl) 3,3-diarylpropylaminen, de toepassing en bereidinghiervan
FI960889A (fi) Naftyyliyhdisteitä, välituotteita, koostumuksia ja menetelmiä
PT941056E (pt) Composicoes de esfingomielinase e sua utilizacao
DE69627513D1 (de) Kochgerät und dessen betriebsverfahren
PT1082330E (pt) Complexo de platina sua preparacao e sua aplicacao terapeutica
NO986034D0 (no) Kombinasjoner omfattende VX 478, ZidovudÞn, FTC og/eller 3TC for anvendelse
DK0840548T3 (da) Synergistisk, herbicid sammensætning samt fremgangsmåde til fremstilling deraf
BR9508110A (pt) Derivado de triterpeno e composição médica
PT935692E (pt) Tratamento de tecido com celulase e oxidoredutase
FI963334A (fi) Tyrosinaasista peräisin olevat eristetyt peptidit ja niiden käyttö
DK60893D0 (da) Piperidinderivater, deres fremstilling og anvendelse
BR9800753B1 (pt) composição cosmética e/ou dermatológica e uso de uma composição.
PT826679E (pt) Compostos de naftilo intermediarios composicoes e metodos de utilizacao
ITMI981895A0 (it) Composizione cosmetica e/o idratante
BR9610382A (pt) Composição de tratamento do cableo
NO972821D0 (no) 1-C-perfluoralkylglycosider, deres fremstilling og anvendelse
EE200000018A (et) 6-pürrolidiin-2-üülpüridiinid, nende valmistamine ja terapeutiline kasutamine
KR960026478U (ko) 골절기
FI963720A (fi) N-aryyli- ja N-alkyylisulfonyyliaminaalit tuholaisten torjunta-aineina
PT101949A (pt) Boneco com elevacao simultania de bracos, pernas e abertura de olhos
FI972988A (fi) Menetelmiä ja farmaseuttisia koostumuksia, joissa käytetään desmetyyliselegiliiniä

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20031231

KB4A Valid patent at the end of a year

Effective date: 20041231

FG1Y Spc granted

Free format text: PRODUCT NAME: KIVEXA; NAT. REGISTRATION NO/DATE: C(2004)5373 20041217; FIRST REGISTRATION: EU/1/04/298/001-002

Spc suppl protection certif: C20050002 00007

Filing date: 20050512

Extension date: 20191217

KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20091231

KB4A Valid patent at the end of a year

Effective date: 20101231

SPCM Correction and amendment to the data concerning application for a supplementary protection certificate

Spc suppl protection certif: C20050002 00007

Extension date: 20191222

SPCX Term of validity of supplementary protection expired

Spc suppl protection certif: 00007

Extension date: 20211209